<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Advances in Molecular Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Advances in Molecular Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Успехи молекулярной онкологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-805X</issn><issn publication-format="electronic">2413-3787</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">728</article-id><article-id pub-id-type="doi">10.17650/2313-805X-2024-11-4-41-53</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">The role of methionine cycle disruption in the initiation and progression of malignant tumors</article-title><trans-title-group xml:lang="ru"><trans-title>Роль нарушения цикла метионина в инициации и прогрессии злокачественных опухолей</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8142-4283</contrib-id><name-alternatives><name xml:lang="en"><surname>Ruksha</surname><given-names>T. G.</given-names></name><name xml:lang="ru"><surname>Рукша</surname><given-names>Т. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Tatiana Gennadievna Ruksha</p><p>1 Partizanа Zheleznyakа St., Krasnoyarsk 660022</p></bio><bio xml:lang="ru"><p>Татьяна Геннадьевна Рукша</p><p>660022 Красноярск, ул. Партизана Железняка, 1</p></bio><email>tatyana_ruksha@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8518-2450</contrib-id><name-alternatives><name xml:lang="en"><surname>Kurbat</surname><given-names>M. N.</given-names></name><name xml:lang="ru"><surname>Курбат</surname><given-names>М. Н.</given-names></name></name-alternatives><address><country country="BY">Belarus</country></address><bio xml:lang="en"><p>80 Gorkogo St., Grodno 230009</p></bio><bio xml:lang="ru"><p>230009 Гродно, ул. Горького, 80</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6801-3452</contrib-id><name-alternatives><name xml:lang="en"><surname>Palkina</surname><given-names>N. V.</given-names></name><name xml:lang="ru"><surname>Палкина</surname><given-names>Н. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Partizanа Zheleznyakа St., Krasnoyarsk 660022</p></bio><bio xml:lang="ru"><p>660022 Красноярск, ул. Партизана Железняка, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kutsenko</surname><given-names>V. A.</given-names></name><name xml:lang="ru"><surname>Куценко</surname><given-names>В. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Partizanа Zheleznyakа St., Krasnoyarsk 660022</p></bio><bio xml:lang="ru"><p>660022 Красноярск, ул. Партизана Железняка, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Grodno State Medical University</institution></aff><aff><institution xml:lang="ru">УО «Гродненский государственный медицинский университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2024</year></pub-date><volume>11</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>41</fpage><lpage>53</lpage><history><date date-type="received" iso-8601-date="2024-12-09"><day>09</day><month>12</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-12-09"><day>09</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Ruksha T.G., Kurbat M.N., Palkina N.V., Kutsenko V.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Рукша Т.Г., Курбат М.Н., Палкина Н.В., Куценко В.А.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Ruksha T.G., Kurbat M.N., Palkina N.V., Kutsenko V.A.</copyright-holder><copyright-holder xml:lang="ru">Рукша Т.Г., Курбат М.Н., Палкина Н.В., Куценко В.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://umo.abvpress.ru/jour/article/view/728">https://umo.abvpress.ru/jour/article/view/728</self-uri><abstract xml:lang="en"><p>The methionine cycle is responsible for the metabolism of substances associated with methionine, one of the essential amino acids for protein synthesis. The methionine cycle dysregulation leads to non-proteinogenic amino acid homocysteine accumulation that can have a negative impact on a health. Numerous studies describe homocysteine effect on cardiovascular pathology development but its role in carcinogenesis remains poorly understood. Therefore, the purpose of this review is to analyze scientific data regarding the role of methionine catabolism dysregulation in a cell neoplastic transformation and tumor growth. Understanding cellular alterations of methionine metabolism is important for novel anti-cancer drugs development as well as establishing approaches for combinatorial treatment strategies aiming to overcome metabolic plasticity of cancer cells and their drug resistance.</p></abstract><trans-abstract xml:lang="ru"><p>Метиониновый цикл отвечает за обмен веществ, связанных с метионином – одним из незаменимых аминокислотных компонентов белков. при нарушении регуляции этого процесса происходит накопление непротеиногенной аминокислоты гомоцистеина, что может негативно влиять на организм человека. Существует множество исследований, посвященных изучению воздействия данных нарушений на развитие болезней системы кровообращения, однако их роль в развитии злокачественных новообразований остается малоизученной. Цель обзора – проанализировать научные работы, в которых рассматривается влияние сбоя регуляции метионинового катаболизма на возникновение и прогрессирование опухолевого роста. Понимание метаболических изменений, связанных с канцерогенезом, имеет большое значение для разработки новых классов терапевтических препаратов, а также стратегий комбинированного противоопухолевого лечения, в том числе направленных на преодоление метаболических особенностей опухолевых клеток.</p></trans-abstract><kwd-group xml:lang="en"><kwd>methionine</kwd><kwd>homocysteine</kwd><kwd>carcinogenesis</kwd><kwd>tumor progression</kwd><kwd>chemotherapy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>метионин</kwd><kwd>гомоцистеин</kwd><kwd>канцерогенез</kwd><kwd>опухолевая прогрессия</kwd><kwd>химиотерапия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Kim S., Fenech M.F., Kim P.J. Nutritionally recommended food for semi-to strict vegetarian diets based on large-scale nutrient composition data. Sci Rep 2018;8(1):4344. DOI: 10.1038/s41598-018-22691-1</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Jubinville É., Milad N., Maranda-Robitaille M. et al. Critical importance of dietary methionine and choline in the maintenance of lung homeostasis during normal and cigarette smoke exposure conditions. Am J Physiol Lung Cell Mol Physiol 2021;319(2):L391–402. DOI: 10.1152/ajplung.00353.2019</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Sanderson S.M., Gao X., Dai Z., Locasale J.W. Methionine metabolism in health and cancer: a nexus of diet and precision medicine. Nat Rev Cancer. 2019;19(11):625–37. DOI: 10.1038/s41568-019-0187-8</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Li Z., Wang F., Liang B. et al. Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication. Signal Transduct Target Ther 2020;5(1):280. DOI: 10.1038/s41392-020-00349-7</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Austin R.C., Lentz S.R., Werstuck G.H. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 2004;11(1):S56–64. DOI: 10.1038/sj.cdd.4401451</mixed-citation></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Pokrovsky V.S., Abo Kura L., Demidova E.A. et al. Methionine dependence of cancer cells is a target of methioninase. Biokhimiya = Biochemistry 2023;88(7):1162–72. (In Russ.). DOI: 10.31857/S0320972523070072</mixed-citation><mixed-citation xml:lang="ru">Покровский В.С., Або Кура Л., Демидова Е.А. и др. Метиониновая зависимость раковых клеток – мишень метиониназы. Биохимия 2023;88(7):1162–72. DOI: 10.31857/S0320972523070072</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><mixed-citation>Muñoz-Esparza N.C., Latorre-Moratalla M.L., Comas-Basté O. et al. Polyamines in food. Front Nutr 2019;6:108. DOI: 10.3389/fnut.2019.00108</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Mendoza J., Purchal M., Yamada K., Koutmos M. Structure of full-length cobalamin-dependent methionine synthase and cofactor loading captured in crystallo. Nat Commun 2023;14(1):6365. DOI: 10.1038/s41467-023-42037-4</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Blake G.E.T., Zhao X., Yung H.W. et al. Defective folate metabolism causes germline epigenetic instability and distinguishes Hira as a phenotype inheritance biomarker. Nat Commun 2021;12(1):3714. DOI: 10.1038/s41467-021-24036-5</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Suthandiram S., Gan G.G., Zain S.M. et al. Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population. J Hum Genet 2014;59(5):280–7. DOI: 10.1038/jhg.2014.19</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Wan L., Li Y., Zhang Z. et al. Methylenetetrahydrofolate reductase and psychiatric diseases. Transl Psychiatry 2018;8(1):242. DOI: 10.1038/s41398-018-0276-6</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Reeves S.G., Meldrum C., Groombridge C. et al. MTHFR 677 C&gt;T and 1298 A&gt;C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Eur J Hum Genet 2009;17(5):629–35. DOI: 10.1038/ejhg.2008.239</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Poursalehi D., Lotfi K., Mirzaei S. et al. Association between methyl donor nutrients and metabolic health status in overweight and obese adolescents. Sci Rep 2022;12(1):17045. DOI: 10.1038/s41598-022-21602-9</mixed-citation></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Tseimakh I.Ya., Kostyuchenko G.I., Bogachev D.E. Effect of folic acid in patients with lung damage caused by coronavirus SARS-CoV-2. Sibirskoe meditsinskoe obozrenie = Siberian Medical Review 2021;(6):60–9. (In Russ.). DOI: 10.20333/25000136-2021-6-60-69</mixed-citation><mixed-citation xml:lang="ru">Цеймах И.Я., Костюченко Г.И., Богачев Д.Е. и др. Эффекты фолиевой кислоты у больных с поражением легких, вызванным коронавирусом SARS-CoV-2. Сибирское медицинское обозрение 2021;(6):60–9. DOI: 10.20333/25000136-2021-6-60-69</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><mixed-citation>Xue Y., Lu F., Chang Z. et al. Intermittent dietary methionine deprivation facilitates tumoral ferroptosis and synergizes with checkpoint blockade. Nat Commun 2023;14(1):4758. DOI: 10.1038/s41467-023-40518-0</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Durand P., Prost M., Loreau N. et al. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 2001;81(5):645–72. DOI: 10.1038/labinvest.3780275</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Hasan T., Arora R., Bansal A.K. et al. Disturbed homocysteine metabolism is associated with cancer. Exp Mol Med 2019;51(2):1–13. DOI: 10.1038/s12276-019-0216-4</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Lim J.M., Kim G., Levine R.L. Methionine in Proteins: It’s Not Just for Protein Initiation Anymore. Neurochem Res 2019;44(1):247–57. DOI: 10.1007/s11064-017-2460-0</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Weissbach H., Resnick L., Brot N. Methionine sulfoxide reductases: history and cellular role in protecting against oxidative damage. Biochim Biophys Acta 2005;1703(2):203–12. DOI: 10.1016/j.bbapap.2004.10.004</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Ohno M., Takano N., Hidaka K. et al. Oxidative stress accelerates intestinal tumorigenesis by enhancing 8-oxoguanine-mediated mutagenesis in MUTYH-deficient mice. Genome Res 2024;34(1):47–56. DOI: 10.1101/gr.278326.123</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Milligan J.R., Aguilera J.A., Ly A. et al. Repair of oxidative DNA damage by amino acids. Nucleic Acids Res 2003;31(21):6258–63. DOI: 10.1093/nar/gkg816</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Zhang L., Xu R., Ma X. et al. Mechanism of arterial injury exacerbated by hyperhomocysteinemia in spontaneously hypertensive rats. Sci Rep 2023;13(1):2482. DOI: 10.1038/s41598-023-28731-9</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Lubos E., Loscalzo J., Handy D.E. Homocysteine and glutathione peroxidase-1. Antioxid Redox Signal 2007;9(11):1923–40. DOI: 10.1089/ars.2007.1771</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Zeng X.K., Guan Y.F., Remick D.G., Wang X. Signal pathways underlying homocysteine-induced production of MCP-1 and IL-8 in cultured human whole blood. Acta Pharmacol Sin 2005;26(1):85–91. DOI: 10.1111/j.1745-7254.2005.00005.x</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Villalobo A., Berchtold M.W. The Role of Calmodulin in Tumor Cell Migration, Invasiveness, and Metastasis. Int J Mol Sci 2020;21(3):765. PMID: 31991573. DOI: 10.3390/ijms21030765</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>You M., Xie Z., Zhang N. et al. Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. Signal Transduct Target Ther 2023;8(1):196. DOI: 10.1038/s41392-023-01442-3</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Kadam M.S., Burra V.L.S.P. S-adenosyl-l-methionine interaction signatures in methyltransferases. J Biomol Struct Dyn 2024;42(6):3166–76. DOI: 10.1080/07391102.2023.2217679</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Wu Y.L., Lin Z.J., Li C.C. et al. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Signal Transduct Target Ther 2023;8(1):98. DOI: 10.1038/s41392-023-01333-7</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Moore L.D., Le T., Fan G. DNA methylation and its basic function. Neuropsychopharmacology 2013;38(1):23–38. DOI: 10.1038/npp.2012.112</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Luo J., Li Y.N., Wang F. et al. S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer. Int J Biol Sci 2010;6(7):784–95. DOI: 10.7150/ijbs.6.784</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Kong Y., Rose C.M., Cass A.A. et al. Transposable element expression in tumors is associated with immune infiltration and increased antigenicity. Nat Commun 2019;10(1):5228. DOI: 10.1038/s41467-019-13035-2</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Shah A.H., Govindarajan V., Doucet-O’Hare T.T. et al. Differential expression of an endogenous retroviral element [HERV-K(HML-6)] is associated with reduced survival in glioblastoma patients. Sci Rep 2022;12(1):6902. DOI: 10.1038/s41598-022-10914-5</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Van Tongelen A., Loriot A., De Smet C. Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes. Cancer Lett 2017;396:130–7. DOI: 10.1016/j.canlet.2017.03.029</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Li G., Li D., Wu C. et al. Homocysteine-targeting compounds as a new treatment strategy for diabetic wounds via inhibition of the histone methyltransferase SET7/9. Exp Mol Med 2022;54(7):988–98. DOI: 10.1038/s12276-022-00804-1</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Erichsen L., Ghanjati F., Beermann A. et al. Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis. Sci Rep 2018;8(1):6051. DOI: 10.1038/s41598-018-23158-z</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Soltani M., Zhao Y., Xia Z. et al. The importance of cellular metabolic pathways in pathogenesis and selective treatments of hematological malignancies. Front Oncol 2021;11:767026. DOI: 10.3389/fonc.2021.767026</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Bian Y., Li W., Kremer D.M. et al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature 2020;585(7824):277–82. DOI: 10.1038/s41586-020-2682-1</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Stern P.H., Hoffman R.M. Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J Natl Cancer Inst 1986;76(4):629–39. DOI: 10.1093/jnci/76.4.629</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Sedillo J.C., Cryns V.L. Targeting the methionine addiction of cancer. Am J Cancer Res 2022;12(5):2249–76.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Wang Z., Yip L.Y., Lee J.H.J. et al. Methionine is a metabolic dependency of tumor-initiating cells. Nat Med 2019;25(5):825–37. PMID: 31061538. DOI: 10.1038/s41591-019-0423-5</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Yang H.B., Xu Y.Y., Zhao X.N. et al. Acetylation of MAT IIα represses tumour cell growth and is decreased in human hepatocellular cancer. Nat Commun 2015;6:6973. DOI: 10.1038/ncomms7973</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Gao X., Sanderson S.M., Dai Z. et al. Dietary methionine influences therapy in mouse cancer models and alters human metabolism. Nature 2019;572(7769):397–401. DOI: 10.1038/s41586-019-1437-3</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Lee B.C., Kaya A., Gladyshev V.N. Methionine restriction and life-span control. Ann N Y Acad Sci 2016;1363:116–24. DOI: 10.1111/nyas.12973</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Abo Qoura L., Balakin K.V., Hoffman R.M., Pokrovsky V.S. The potential of methioninase for cancer treatment. Biochim Biophys Acta Rev Cancer 2024;1879(4):189122. DOI: 10.1016/j.bbcan.2024.189122</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Lee B.C., Kaya A., Ma S. et al. Methionine restriction extends lifespan of Drosophila melanogaster under conditions of low amino-acid status. Nat Commun 2014;5:3592. DOI: 10.1038/ncomms4592</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Fontana L., Weiss E.P., Villareal D.T. et al. Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell 2008;7(5):681–7. DOI: 10.1111/j.1474-9726.2008.00417.x</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Wang L., Cai H., Hu Y. et al. A pharmacological probe identifies cystathionine β-synthase as a new negative regulator for ferroptosis. Cell Death Dis 2018;9(10):1005. DOI: 10.1038/s41419-018-1063-2</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Booher K., Lin D.W., Borrego S.L., Kaiser P. Downregulation of Cdc6 and pre-replication complexes in response to methionine stress in breast cancer cells. Cell Cycle 2012;11(23):4414–23. DOI: 10.4161/cc.22767</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Borrego S.L., Lin D.W., Kaiser P. Isolation and characterization of methionine-independent clones from methionine-dependent cancer cells. Methods Mol Biol 2019;1866:37–48. DOI: 10.1007/978-1-4939-8796-2_4</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Li F., Liu P., Mi W. et al. Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 inhibition in liver cancer. Nat Cancer 2024;5(1):131–46. DOI: 10.1038/s43018-023-00671-3</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Grigorash B.B., van Essen D., Liang G. et al. p16High senescence restricts cellular plasticity during somatic cell reprogramming. Nat Cell Biol 2023;25(9):1265–78. DOI: 10.1038/s41556-023-01214-9</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Yang C., Ou Y., Zhou Q. et al. Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment. Cell Death Dis 2023;14(8):525. DOI: 10.1038/s41419-023-06050-1</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Li J.T., Yang H., Lei M.Z. et al. Dietary folate drives methionine metabolism to promote cancer development by stabilizing MAT IIA. Signal Transduct Target Ther 2022;7(1):192. DOI: 10.1038/s41392-022-01017-8</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Yang H., Huang Z.Z., Wang J., Lu S.C. The role of c-Myb and Sp1 in the up-regulation of methionine adenosyltransferase 2A gene expression in human hepatocellular carcinoma. FASEB J 2001;15(9):1507–16. DOI: 10.1096/fj.01-0040com</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Yang H., Sadda M.R., Yu V. et al. Induction of human methionine adenosyltransferase 2A expression by tumor necrosis factor alpha. Role of NF-kappa B and AP-1. J Biol Chem 2003;278(51):50887–96. DOI: 10.1074/jbc.M307600200</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Strekalova E., Malin D., Weisenhorn E.M.M. et al. S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells. Breast Cancer Res Treat 2019;175(1):39–50. DOI: 10.1007/s10549-019-05146-7</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>He D., Feng H., Sundberg B. et al. Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. Mol Cell 2022;82(16):3045–60.e11. DOI: 10.1016/j.molcel.2022.06.005</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Roybal C.N., Yang S., Sun C.W. et al. Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem 2004;279(15):14844–52. DOI: 10.1074/jbc.M312948200</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Zhao W.X., Liu Z.F., Li X.L., Li Z. Correlations of serum homocysteine, VEGF and gastrin 17 with gastric cancer and precancerous lesions. Eur Rev Med Pharmacol Sci 2019;23(10):4192–8. DOI: 10.26355/eurrev_201905_17922</mixed-citation></ref></ref-list></back></article>
